Siga Technologies (SIGA) Free Cash Flow (2010 - 2025)
Siga Technologies (SIGA) posted Free Cash Flow of -$10.1 million for Q3 2025, down 116.02% on a QoQ basis from $63.1 million in Q2 2025, and down 36.43% year-over-year from -$15.9 million in Q3 2024.
Siga Technologies (SIGA) Free Cash Flow (2010 - 2025) Analysis & Trends
Siga Technologies' Free Cash Flow history runs 16 years deep, the most recent figure standing at -$10.1 million for Q3 2025.
- Quarterly Free Cash Flow fell 36.43% year-over-year to -$10.1 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $60.0 million (up 23.19% YoY) and the FY2024 annual result came in at $48.7 million, down 48.6% from the prior year.
- Free Cash Flow was -$10.1 million for Q3 2025 at Siga Technologies, down from $63.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$10.1 million in Q3 2025.
- A 5-year average of $13.5 million and a median of -$1.4 million in 2021 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 1276.47% in 2022, while the deepest fall reached 393.58% in 2022.
- Siga Technologies' Free Cash Flow stood at $16.1 million in 2021, then plunged by 150.42% to -$8.1 million in 2022, then surged by 1074.95% to $79.0 million in 2023, then declined by 28.77% to $56.3 million in 2024, then sank by 117.95% to -$10.1 million in 2025.
- Business Quant data shows SIGA's Free Cash Flow at -$10.1 million in Q3 2025, $63.1 million in Q2 2025, and $7.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.10 Mn |
| Sep 30, 2025 | -10.10 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Mar 31, 2025 | 7.04 Mn |
| Mar 31, 2025 | 7.04 Mn |
| Dec 31, 2024 | 56.29 Mn |
| Dec 31, 2024 | 56.29 Mn |
| Sep 30, 2024 | -7.41 Mn |
| Sep 30, 2024 | -7.41 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -3.60 Mn |
| Jun 30, 2023 | -3.60 Mn |